Last updated on February 2018

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Brief description of study

This is a multicenter, open label study to assess the safety and pharmacokinetics of YKP3089 as adjunctive therapy in subjects with partial onset seizures. Initially, subjects taking phenytoin or phenobarbital will be enrolled followed by additional subjects taking anti-epileptic drugs other than phenytoin and phenobarbital to further investigate long-term safety.

Clinical Study Identifier: NCT02535091

Contact Investigators or Research Sites near you

Start Over

Daniel San Juan Orta

Clinical Research Institute
Tlalnepantla, Mexico
  Connect »

Freddy Castro Farfan

Grupo Medico Camino
Distrito Federal, Mexico
  Connect »

Roberto Suástegui Román

Human Science Research Trials
Mexico City, Mexico
  Connect »